Translational physiology: Porcine models of human coronary artery disease: Implications for preclinical trials of therapeutic angiogenesis

Journal of Applied Physiology

Volumn 94, Issue 5, 2003, Pages 1689-1701

  Hughes, G Chad ^a   Post, Mark J ^b   Simons, Michael ^b   Annex, Brian H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Animal models; Coronary disease; Hibernation; Myocardial ischemia

Indexed keywords

GROWTH FACTOR;

ANGINA PECTORIS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; DISEASE MODEL; FIXED STENOSIS MODEL; GENE THERAPY; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HYDRAULIC OCCLUDER MODEL; MYOCARDIAL HIBERNATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; STUNNED HEART MUSCLE; SWINE; THERAPEUTIC ANGIOGENESIS;

EID: 0037404439     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00465.2002     Document Type: Review

References (94)

1. Abdel-aleem S, St. Louis JD, Hughes GC, and Lowe JE. Metabolic changes in the normal and hypoxic neonatal myocardium. Ann NY Acad Sci 874: 254-661, 1999.
2. Afridi I, Kleiman NS, Raizner AE, and Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 91: 663-670, 1995.
3. American Heart Association. 2001 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 2000.
4. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, and Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999.
5. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, and Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997.
6. Beanlands RSB, Hendry PJ, Masters RG, deKemp RA, Woodend K, and Ruddy TD. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 98: II51-II56, 1998.
7. Bernotat-Danielowski S, Sharma HS, Schott RJ, and Schaper W. Generation and localisation of monoclonal antibodies against fibroblast growth factors in ischaemic collateralised porcine myocardium. Cardiovasc Res 27: 1220-1228, 1993.
8. Biswas SS, Hughes GC, Yin B, Baklanov DV, Donovan CL, DeGrado TR, Coleman RE, Lowe JE, Annex BH, and Landolfo KP. Effects of low-dose intramyocardial basic fibroblast growth factor on regional blood flow and function in a porcine model of hibernating myocardium. Surg Forum 50: 122-124, 1999.
9. Bolukoglu H, Liedtke AJ, Nellis SH, Eggleston AM, Subramanian R, and Renstrom B. An animal model of chronic coronary stenosis resulting in hibernating myocardium. Am J Physiol Heart Circ Physiol 263: H20-H29, 1992.
10. Camici P, Ferrannini E, and Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 32: 217-238, 1989.
11. Canver CC and Dame NA. Ultrasonic assessment of internal thoracic artery graft flow in the revascularized heart. Ann Thorac Surg 58: 135-138, 1994.
12. Chareonthaitawee P, Kaufmann PA, Rimoldi O, and Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 50: 151-161, 2001.
13. Chen C, Chen L, Fallon JT, Ma L, Li L, Bow L, Knibbs D, McKay R, Gillam LD, and Waters DD. Functional and structural alterations with 24 h myocardial hibernation and recovery after reperfusion: a pig model of myocardial hibernation. Circulation 94: 507-516, 1996.
14. Chen C, Ma L, Linfert DR, Lai T, Fallon JT, Gillam LD, Waters DD, and Tsongalis GJ. Myocardial cell death and apoptosis in hibernating myocardium. J Am Coll Cardiol 30: 1407-1412, 1997.
15. Cigarroa CG, de Filippi CR, Brickner ME, Alvarez LG, Wait MA, and Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 88: 430-436, 1993.
16. Dean DA, Jia CX, Cabreriza SE, D'Alessandro DA, Dickstein ML, Sardo MJ, Chalik N, and Spotnitz HM. Validation study of a new transit time ultrasonic flow probe for continuous great vessel measurements. ASAIO J 42: M671-M676, 1996.
17. 13N-labeled ammonia and positron emission tomography. J Nucl Cardiol 3: 494-507, 1996.
18. Depre C, Vanoverschelde JLJ, and Taegtmeyer H. Glucose for the heart. Circulation 99: 578-588, 1999.
19. DiCarli MF. Predicting improved function after myocardial revascularization. Curr Opin Cardiol 13: 415-424, 1998.
20. Dobbs S, White FC, Roth DM, and Bloor CM. Effects of age on the coronary collateral circulation. Coron Artery Dis 2: 473-480, 1991.
21. Domkowski PW, Hughes GC, and Lowe JE. Ameroid constrictor versus hydraulic occluder: creation of hibernating myocardium. Ann Thorac Surg 69: 1984, 2000.
22. Elsässer A, Decker E, Kostin S, Hein S, Skwara W, Muller KD, Greiber S, Schaper W, Klövekorn WP, and Schaper J A self-perpetuating vicious cycle of tissue damage in human hibernating myocardium. Mol Cell Biochem 213: 17-28, 2000.
23. Elsässer A, Schlepper M, Klövekorn WP, Cai WJ, Zimmermann R, Muller KD, Strasser R, Kostin S, Gagel C, Munkel B, Schaper W, and Schaper J. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 96: 2920-2931, 1997.
24. Elzinga WE. Ameroid constrictor: uniform closure rates and a calibration procedure. J Appl Physiol 27: 419-421, 1969.
25. 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion. Circulation 99: 2798-2805, 1999.
26. Fallavollita JA, Perry BJ, and Canty JM Jr. F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. Circulation 95: 1900-1909, 1997.
27. Freedman SB and Isner JM. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 136: 54-71, 2002.
28. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, Weissman NJ, Leon MB, Epstein SE, and Kornowski R. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37: 1726-1732, 2001.
29. Görge G, Schmidt T, Ito BR, Pantely GA, and Schaper W. Microvascular and collateral adaptation in swine hearts following progressive coronary artery stenosis. Basic Res Cardiol 84: 524-535, 1989.
30. Greene AS. Application of physiological genomics to the microcirculation. Microcirculation 9: 3-12, 2002.
31. Hearse DJ. The elusive coypu: the importance of collateral flow and the search for an alternative to the dog. Cardiovasc Res 45: 215-219, 2000.
32. Hennessy T, Diamond P, Holligan B, O'Keane C, Hurley J, Codd M, McCarthy C, McCann H, and Sugrue D Correlation of myocardial histologic changes in hibernating myocardium with dobutamine stress echocardiographic findings. Am Heart J 135: 952-959, 1998.
33. Henry T, Annex BH, Azrin M, McKendall GR, Willerson JT, Hendel RC, Giordano FJ, Klein R, Gibson M, Berman DS, Luce CA, and McCluskey ER. Final results of the VIVA trial of rhVEGF for human therapeutic angiogenesis (Abstract). Circulation 100: 1-476, 1999.
34. Heymann MA, Payne BD, Hoffman JIE, and Rudolph AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis 20: 55-79, 1977.
35. Horvath KA, Greene R, Belkind N, Kane B, McPherson DD, and Fullerton DA. Left ventricular functional improvement after transmyocardial laser revascularization. Ann Thorac Surg 66: 721-725, 1998.
36. Hughes HC. Swine in cardiovascular research. Lab Anim Sci 36: 348-350, 1986.
37. Hughes GC. Cellular models of hibernating myocardium: implications for future research. Cardiovasc Res 51: 191-193, 2001.
38. Hughes GC, Abdel-aleem S, Biswas SS, Landolfo KP, and Lowe JE. Transmyocardial laser revascularization: experimental and clinical results. Can J Cardiol 15: 797-806, 1999.
39. Hughes GC, Biswas SS, Yin B, Baklanov DV, Annex BH, Coleman RE, DeGrado TR, Landolfo CK, Landolfo KP, and Lowe JE. A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. J Am Coll Cardiol 39: 1220-1228, 2002.
40. Hughes GC, Biswas SS, Yin B, Baklanov DV, DeGrado TR, Coleman RE, Donovan GC, Lowe JE, Landolfo KP, and Annex BH. Intramyocardial but not intravenous vascular endothelial growth factor improves regional perfusion in hibernating myocardium (Abstract). Circulation 100: 1-476, 1999.
41. 2, and excimer lasers. Ann Thorac Surg 70: 504-509, 2000.
42. Hughes GC, Kypson AP, St. Louis JD, Annex BH, Coleman RE, DeGrado TR, Donovan CL, Lowe JE, and Landolfo KP. Improved perfusion and contractile reserve after transmyocardial laser revascularization in a model of hibernating myocardium. Ann Thorac Surg 67: 1714-1720, 1999.
43. Hughes GC, Landolfo CK, Yin B, DeGrado TR, Coleman RE, Landolfo KP, and Lowe JE. Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused? Ann Thorac Surg 72: 163-168, 2001.
44. Hughes GC, Lowe JE, Kypson AP, St. Louis JD, Pippen AM, Peters KG, Coleman RE, DeGrado TR, Donovan CL, Annex BH, and Landolfo KP. Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. Ann Thorac Surg 66: 2029-2036, 1998.
45. Inou T, Tomoike H, Watanabe K, Kikuchi Y, Mizukami M, Kurozumi T, and Nakamura M. A newly developed x-ray transparent ameroid constrictor for study on progression of gradual coronary stenosis. Basic Res Cardiol 75: 537-543, 1980.
46. Kersten JR, McGough MF, Pagel PS, Tessmer JP, and Warltier DC. Temporal dependence of coronary collateral development. Cardiovasc Res 34: 306-312, 1997.
47. Laham RJ, Rezaee M, Post M, Novicki D, Sellke FW, Pearlman JD, Simons M, and Hung D. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther 292: 795-802, 2000.
48. Lai T, Fallon JT, Liu J, Mangion J, Gillam L, Waters D, and Chen C. Reversibility and pathohistological basis of left ventricular remodeling in hibernating myocardium. Cardiovasc Pathol 9: 323-335, 2000.
49. Landolfo CK, Landolfo KP, Hughes GC, Coleman ER, Coleman RB, and Lowe JE. Intermediate-term clinical outcome following transmyocardial laser revascularization in patients with refractory angina pectoris. Circulation 100: II128-II133, 1999.
50. Leon MB. Direct myocardial laser revascularization using biosense left ventricular electromechanical mapping: final results of the DIRECT randomized trial. Am Coll Cardiol Annual Session 50th Orlando, FL, March 18, 2001.
51. Levin DC. Pathways and functional significance of the coronary collateral circulation. Circulation 50: 831-837, 1974.
52. Litvak J, Siderides LE, and Vineberg A. The experimental production of coronary artery insufficiency and occlusion. Am Heart J 53: 505-518, 1957.
53. Loncar R, Flesche CW, and Deussen A. Coronary reserve of high- and low-flow regions in the dog heart left ventricle. Circulation 98: 262-270, 1998.
54. Mack CA, Patel SR, Schwarz EA, Zanzonico P, Hahn RT, Ilercil A, Devereux RB, Goldsmith SJ, Christian TF, Sanborn TA, Kovesdi I, Hackett N, Isom OW, Crystal RG, and Rosengart TK. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 115: 168-177, 1998.
55. Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, and Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 102: 3098-3103, 2000.
56. Maxwell MP, Hearse DJ, and Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 21: 737-746, 1987.
57. Mélon PG, De Landsheere CM, Degueldre C, Peters JL, Kulbertus HE, and Piérard LA. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 30: 1651-1659, 1997.
58. Millard RW. Induction of functional collaterals in the swine heart. Basic Res Cardiol 76: 468-473, 1981.
59. Moon PF and Smith LJ. General anesthetic techniques in swine. Vet Clin North Am Food Anim Pract 12: 663-691, 1996.
60. Mukherjee D, Bhatt DL, Roe MT, Patel V, and Ellis SG. Direct myocardial revascularization and angiogenesis - how many patients might be eligible? Am J Cardiol 84: 598-600, 1999.
61. O'Konski MS, White FC, Longhurst J, Roth D, and Bloor CM. Ameroid constriction of the proximal left circumflex coronary artery in swine. A model of limited coronary collateral circulation. Am J Cardiovasc Pathol 1: 69-77, 1987.
62. Opie LH. The multifarious spectrum of ischemic left ventricular dysfunction: relevance of new ischemic syndromes. J Mol Cell Cardiol 28: 2403-2414, 1996.
63. Panepinto LM and Phillips RW. The Yucatan miniature pig: characterization and utilization in biomedical research. Lab Anim Sci 36: 344-347, 1986.
64. Papetti M and Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282: C947-C970, 2002.
65. Peale FV Jr and Gerritsen ME. Gene profiling techniques and their application in angiogenesis and vascular development. J Pathol 195: 7-19, 2001.
66. Post MJ, Laham R, Sellke FW, and Simons M. Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc Res 49: 522-531, 2001.
67. Roth DM, Maruoka Y, Rogers J, White FC, Longhurst JC, and Bloor CM. Development of coronary collateral circulation in left circumflex ameroid-occluded swine myocardium. Am J Physiol Heart Circ Physiol 253: H1279-H1288, 1987.
68. Roth DM, White FC, Nichols ML, Dobbs SL, Longhurst JC, and Bloor CM. Effect of long-term exercise on regional myocardial function and coronary collateral development after gradual coronary artery occlusion in pigs. Circulation 82: 1778-1789, 1990.
69. Sato K, Laham RJ, Pearlman JD, Novicki D, Sellke FW, Simons M, and Post MJ. Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia. Ann Thorac Surg 70: 2113-2118, 2000.
70. Sato K, Wu T, Laham RJ, Johnson RB, Douglas P, Li J, Sellke FW, Bunting S, Simons M, and Post MJ Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia. J Am Coll Cardiol 37: 616-623, 2001.
71. Sayeed-Shah U, Mann MJ, Martin J, Grachev S, Reimold S, Laurence R, Dzau V, and Cohn LH. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization. J Thorac Cardiovasc Surg 116: 763-769, 1998.
72. Schaper W. Quo vadis collateral blood flow? A commentary on a highly cited paper. Cardiovasc Res 45: 220-223, 2000.
73. Schaper W and Buschmann I. Arteriogenesis, the good and bad of it. Cardiovasc Res 43: 835-837, 1999.
74. Schaper W and Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circ Res 79: 911-919, 1996.
75. Schaper W, Jageneau A, and Xhonneux R. The development of collateral circulation in the pig and dog heart. Cardiologia 51: 321-335, 1967.
76. Schoebel FC, Frazier OH, Jessurun GAJ, De Jongste MJ, Kadipasaoglu KA, Jax TW, Heintzen MP, Cooley DA, Strauer BE, and Leschke M. Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic concepts. Am Heart J 134: 587-602, 1997.
77. Schwarz ER, Schoendube FA, Kostin S, Schmiedtke N, Schulz G, Buell U, Messmer BJ, Morrison J, Hanrath P, and vom Dahl J. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol 31: 1018-1026, 1998.
78. Sellke FW, Laham RJ, Edelman ER, Pearlman JD, and Simons M. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann Thorac Surg 65: 1540-1544, 1998.
79. Shen YT, Kudej RK, Bishop SP, and Vatner SF. Inotropic reserve and histological appearance of hibernating myocardium in conscious pigs with ameroid-induced coronary stenosis. Basic Res Cardiol 91: 479-485, 1996.
80. Shen YT and Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? Circ Res 76: 479-488, 1995.
81. Simons M. Phase II, multicenter, double-blind, placebo-controlled, dose-finding study for safety, pharmacokinetics, and efficacy of recombinant fibroblast growth factor (fFGF-2) in subjects with coronary artery disease (CAD). Am Coll Cardiol Annual Session 49th Anaheim, CA, March 12, 2000.
82. Simons M. Therapeutic coronary angiogenesis: a fronte praecipitium a tergo lupi? Am J Physiol Heart Circ Physiol 280: H1923-H1927, 2001.
83. St. Louis JD, Hughes GC, Kypson AP, DeGrado TR, Donovan CL, Coleman RE, Yin B, Steenbergen C, Landolfo KP, and Lowe JE An experimental model of chronic myocardial hibernation. Ann Thorac Surg 69: 1351-1357, 2000.
84. Swindle MM, Horneffer PJ, Gardner TJ, Gott VL, Hall TS, Stuart RS, Baumgartner WA, Borkon AM, Galloway E, and Reitz BA. Anatomic and anesthetic considerations in experimental and cardiopulmonary surgery in swine. Lab Anim Sci 36: 357-361, 1986.
85. Symes JF, Losordo DW, Vale PR, Lathi KG, Esakof DD, Mayskiy M, and Isner JM. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68: 830-836, 1999.
86. Symons JD, Pitsillides KF, and Longhurst JC. Chronic reduction of myocardial ischemia does not attenuate coronary collateral development in miniswine. Circulation 86: 660-671, 1992.
87. Unger EF. Experimental evaluation of coronary collateral development. Cardiovasc Res 49: 497-506, 2001.
88. Vanoverschelde JLJ and Melin JA. The pathophysiology of myocardial hibernation: current controversies and future directions. Prog Cardiovasc Dis 43: 387-398, 2001.
89. Verdouw PD, van den Doel MA, de Zeeuw S, and Duncker DJ. Animal models in the study of myocardial ischaemia and ischaemic syndromes. Cardiovasc Res 39: 121-135, 1998.
90. Vineberg A, Mahanti B, and Litvak J. Experimental gradual coronary artery constriction by ameroid constrictors. Surgery 47: 765-771, 1960.
91. Weihrauch D, Tessmer J, Warltier DC, and Chilian WM. Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium. Am J Physiol Heart Circ Physiol 275: H969-H976, 1998.
92. White FC and Bloor CM. Coronary collateral circulation in the pig: correlation of collateral flow with coronary bed size. Basic Res Cardiol 76: 189-196, 1981.
93. White FC, Carroll SM, Magnet A, and Bloor CM. Coronary collateral development in swine after coronary artery occlusion. Circ Res 71: 1490-1500, 1992.
94. White FC, Roth DM, and Bloor CM. The pig as a model for myocardial ischemia and exercise. Lab Anim Sci 36: 351-356, 1986.